Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
This page is not indexed by search engines while we improve data quality.
Zymeworks Inc — Human Necessities
Zymeworks Inc holds 108 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Zymeworks Inc |
| Technology | Human Necessities |
| Patents in slice | 108 |
| Recent patents in slice | 5 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Zymeworks Inc to Human Necessities.
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Recent filings
Latest patents from Zymeworks Inc in Human Necessities.
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Cysteine engineered antibody constructs, conjugates and methods of use
US-2026042847-A1 · Feb 12, 2026 · US
Related pages
Navigate to parent entity pages.